Literature DB >> 28042737

Thyroid hormone level is associated with the frequency and severity of Guillain-Barré syndrome.

Yuanyuan Huang1, Zhaojian Ying2, Zhibo Chen1, Weiwei Xiang1, Zhongqian Su1, Weiwei Quan1, Yiyun Weng1, Xu Zhang1.   

Abstract

OBJECTIVE: Guillain-Barré syndrome (GBS) is a neurodegenerative and inflammatory demyelination disorder, and oxidative stress is concerned with the pathogenesis of the disease. Also, we found that thyroid hormone level is correlated to the oxidative and antioxidant status in previous studies. Our study was aimed to find the possible relationship between the frequency and severity of GBS and thyroid hormone levels.
MATERIALS AND METHODS: We measured serum levels of thyroid-stimulating hormone (TSH), free thyroxine (FT4) and free triiodothyronine (FT3) in 238 individuals, including 90 GBS, 44 multiple sclerosis and 104 healthy controls.
RESULTS: Our findings demonstrate that the patients with GBS had lower TSH and higher FT4, FT4/FT3 than healthy controls in the normal range. Furthermore, it was also shown in our study that TSH levels in patients with GBS were correlated with disease severity measured by the Hughes Functional Grading Scale.
CONCLUSION: Lower TSH, higher FT4 and FT4/FT3 stand for the oxidative status and are associated with the incidence and severity of GBS.

Entities:  

Keywords:  FT4; FT4/FT3; Guillain–Barré syndrome; TSH; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28042737     DOI: 10.1080/00207454.2016.1278541

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  The prediction effects of thyroid function in the severity of Guillain-Barré syndrome.

Authors:  Lingxin Kong; Xiujuan Wu; Yanwei Cheng; Shan Liu; Kangding Liu; Chunrong Li
Journal:  Neurol Sci       Date:  2022-04-26       Impact factor: 3.830

2.  Free thyroxine level is associated with both relapse rate and poor neurofunction in first-attack Neuromyelitis Optica Spectrum Disorder (NMOSD) patients.

Authors:  Qianyi He; Lifeng Li; Yanfei Li; Yanhui Lu; Kaimin Wu; Ruiyi Zhang; Junfang Teng; Jie Zhao; Yanjie Jia
Journal:  BMC Neurol       Date:  2019-12-18       Impact factor: 2.474

3.  Guillain-Barré Syndrome developing in a patient with Graves' Disease.

Authors:  Anirban Majumder; Sagar Basu
Journal:  J ASEAN Fed Endocr Soc       Date:  2019-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.